JPMorgan Chase & Co. restated their overweight rating on shares of Hikma Pharmaceuticals (LON:HIK – Free Report) in a report released on Friday morning, Marketbeat.com reports. Separately, Berenberg ...

Hikma Pharmaceuticals PLC closed 10.00% short of its 52-week high of £23.60, which the company reached on February 13th.

In a report released today, James Gordon from J.P. Morgan reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report). The ...

RBC Capital analyst Alistair Campbell reiterated a Buy rating on Hikma Pharmaceuticals (HIK – Research Report) today and set a price target of ...

Hikma Pharmaceuticals PLC HIK shares rallied 1.32% to £23.10 Friday, on what proved to be an all-around poor trading session for the stock market, with the FTSE 100 Index UKX falling 0.04% to ...

AMMAN — Hikma Pharmaceuticals PLC posted 'robust' financial results for 2024, with revenue climbing 9 per cent to $3.127 ...

For example, the Hikma Pharmaceuticals PLC (LON:HIK) share price is up 23% in the last 5 years, clearly besting the market return of around 3.1% (ignoring dividends). However, more recent returns ...

Axsome Therapeutics AXSM announced that it has entered into a settlement agreement with Hikma Pharmaceuticals related to ...

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Epirubicin combined with mindfulness intervention significantly improved clinical outcomes in patients with urinary system tumors and depression, demonstrating its potential for broader clinical ...

Egypt - Elsewedy Electric is expected to start supplying building materials to the Ras El-Hikma project on Egypt’s North Coast within two months, the company’s Chairman Ahmed Elsewedy told Al Arabiya ...